Stifel analyst Andrew Partheniou raised the firm’s price target on Trulieve Cannabis to C$9 from C$8 and keeps a Buy rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TCNNF:
- Rising High: Exclusive talk with cannabis market research firm BDSA
- Trulieve Reports Second Quarter 2023 Results Highlighting Progress on 2023 Plan
- Here’s What You Missed in Cannabis This Week
- Trulieve Cannabis price target lowered to C$8 from C$20 at Stifel
- Rising High: Exclusive talk with biotech company Tryp Therapeutics